Palvella Therapeutics

0 followers


Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.

Employees

11-50

Links

Org chart

Wes Kaupinen
President & CEO

Wes Kaupinen

Collapse
Braham Shroot
Chief Scientific Officer
Jeff Martini
Chief Scientific Officer
Kathy Goin
Chief Operating Officer
Pam Swiggard
Vice President Regulatory Affairs
Emily Cook
SVP, Clinical Operations
Kathleen McGowan
VP, Finance & Operations
Jason Connor
VP, Clinical & Biostatistics
Alexis Lawthers
Clinical Trial Manager
Sam Vuong
Senior Manager, CMC
Matthew Korenberg
Chief Financial Officer